AtaiBeckley is being acquired by Eli Lilly at $6.75/share plus a $2.50 CVR—see the deal terms, milestone risks, and pipeline ...

The State Department is cracking down on universities accepting funding from foreign entities on U S. government watch lists.

Equity Insider News Commentary, There is a specific moment in a mining project's life when it stops being a geological idea and starts being ...

Combined company positioned to advance portfolio of biologic agents designed to improve outcomes in patients with numerous immunologically-driven disorders ...

DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT - CUSIP: 23306J309), a late-stage biopharmaceutical company, today reported financial results for the Second Quarter ...